253 results
Page 4 of 13
8-K
EX-99.1
hodgxtw8i099chwk 00
28 Feb 22
MIMEDX Announces Fourth Quarter and Full Year 2021
12:00am
8-K
EX-99.1
nx6 wbbw81c
10 Jan 22
Results of Operations and Financial Condition
8:05am
8-K
EX-99.1
2fzovdnpooi
7 Dec 21
Regulation FD Disclosure
12:45pm
8-K
EX-99.2
x52 gye5nsydqei17y
7 Dec 21
Regulation FD Disclosure
12:45pm
8-K
EX-99.1
rxkankt0 53vyeq
22 Nov 21
Regulation FD Disclosure
8:01am
8-K
EX-99.1
zgq2k5klmjv
2 Nov 21
MIMEDX Announces Third Quarter 2021
4:53pm
8-K
mjdbta8gocxtsfto
13 Sep 21
MIMEDX Reports Top-line Data from Two Late-Stage Musculoskeletal Trials with Proprietary Amniotic Tissue Technology
6:33am
8-K
EX-99.1
icqksn65fm1sayfr6
13 Sep 21
MIMEDX Reports Top-line Data from Two Late-Stage Musculoskeletal Trials with Proprietary Amniotic Tissue Technology
6:33am
8-K
EX-99.2
d7j1 k6xmtuhfyh
13 Sep 21
MIMEDX Reports Top-line Data from Two Late-Stage Musculoskeletal Trials with Proprietary Amniotic Tissue Technology
6:33am
8-K
EX-99.1
nursbn3 mw18
3 Aug 21
MIMEDX Announces Second Quarter 2021
5:26pm
8-K
EX-99.1
3kw2kz
23 Jun 21
Results of Operations and Financial Condition
8:33am
8-K
EX-99.1
7vjmc
12 May 21
Regulation FD Disclosure
8:20am
8-K
nth4n 899t
12 May 21
Regulation FD Disclosure
8:20am
DEFA14A
9ckv32bdr1x
7 May 21
Additional proxy soliciting materials
10:56am
DFAN14A
31yv5ipwpuleulh
4 May 21
Additional proxy materials by non-management
5:00pm
DFAN14A
ma5y 2k66v1ow0
4 May 21
Additional proxy materials by non-management
2:59pm